Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
M. Bolla(Centre Hospitalier Universitaire de Grenoble), M. Piérart(Unknown), Guy Storme(Mathys (Netherlands)), Abraham Kuten(Rambam Health Care Campus), Laurence Collette(GlaxoSmithKline (Belgium)), Thierry Gil(Institut Jules Bordet), Jacques Bernier(Ospedale San Giovanni Bellinzona), René‐Olivier Mirimanoff(University of Lausanne), Dionisio González, Padraig Warde(University Health Network), J.B. Dubois(CEA Valduc), Cora N. Sternberg(Cornell University)
Cited by 1,560
Related Papers
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k